These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34441032)

  • 1. TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
    Kakkas I; Tsinti G; Kalala F; Farmaki E; Kourakli A; Kapousouzi A; Dimou M; Kalaitzidou V; Sevdali E; Peristeri AM; Tsiouma G; Patiou P; Papadimitriou E; Vassilakopoulos TP; Panayiotidis P; Kioumi A; Symeonidis A; Speletas M
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441032
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
    Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
    Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.
    Pulvirenti F; Zuntini R; Milito C; Specchia F; Spadaro G; Danieli MG; Pession A; Quinti I; Ferrari S
    J Immunol Res; 2016; 2016():8390356. PubMed ID: 27123465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
    Waldrep ML; Zhuang Y; Schroeder HW
    BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
    Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
    J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous alterations of TNFRSF13B/TACI in tonsillar hypertrophy and sarcoidosis.
    Speletas M; Salzer U; Florou Z; Petinaki E; Daniil Z; Bardaka F; Gourgoulianis KI; Skoulakis C; Germenis AE
    Clin Dev Immunol; 2013; 2013():532437. PubMed ID: 23956760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
    Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
    J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVID-associated TACI mutations affect autoreactive B cell selection and activation.
    Romberg N; Chamberlain N; Saadoun D; Gentile M; Kinnunen T; Ng YS; Virdee M; Menard L; Cantaert T; Morbach H; Rachid R; Martinez-Pomar N; Matamoros N; Geha R; Grimbacher B; Cerutti A; Cunningham-Rundles C; Meffre E
    J Clin Invest; 2013 Oct; 123(10):4283-93. PubMed ID: 24051380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
    Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
    Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
    Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
    Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
    Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
    Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
    J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACI mutation in common variable immunodeficiency and IgA deficiency.
    Rachid R; Castigli E; Geha RS; Bonilla FA
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
    Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
    Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.